Politics · 1 sources covering this

FDA approves breakthrough pancreatic cancer drug proven to extend survival

The Food and Drug Administration on Wednesday rubber-stamped a new drug to treat pancreatic cancer and substantially extend the lives of patients. The drug, daraxonrasib, is produced by Revolution Medicines and was approved for individuals with metastatic pancreatic cancer who did not see success with chemotherapy. Doctors have sung the praises of the drug, and […]

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Washington ExaminerLean R·1h ago
FDA approves breakthrough pancreatic cancer drug proven to extend survival
The Food and Drug Administration on Wednesday rubber-stamped a new drug to treat pancreatic cancer and substantially extend the lives of patients. The drug, daraxonrasib, is produced by Revolution Medicines and was approved for individuals with metastatic pancreatic cancer who did not see success with chemotherapy. Doctors have sung the praises of the drug, and […]
Read at Washington Examiner →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/4d770f3ab4811c8ab0424598af239c7b7b3ebe50"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="FDA approves breakthrough pancreatic cancer drug proven to extend survival"></iframe>

FDA approves breakthrough pancreatic cancer drug proven to extend survival

How 1 sources are covering this